Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$2.01B |
| 2 |
Broadcom
AVGO
|
+$1.41B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$978M |
| 4 |
JPMorgan Chase
JPM
|
+$714M |
| 5 |
Tesla
TSLA
|
+$626M |
Top Sells
| 1 |
Honeywell
HON
|
+$1.68B |
| 2 |
Visa
V
|
+$1.41B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$855M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$550M |
Sector Composition
| 1 | Technology | 34.36% |
| 2 | Financials | 12.76% |
| 3 | Consumer Discretionary | 11.44% |
| 4 | Communication Services | 8.74% |
| 5 | Healthcare | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
BrightSpring Health Services, Inc. Tangible Equity Unit
BTSGU
$771M
| $2.71M | ﹤0.01% |
32,816
+797
| +2% | +$65.8K |
|
2002
XPEL
XPEL
$990M
| $2.7M | ﹤0.01% |
75,156
+7,352
| +11% | +$264K |
|
2003
Vanguard FTSE Developed Markets ETF
VEA
$175B
| $2.7M | ﹤0.01% |
47,286
+16,387
| +53% | +$934K |
|
|
SNRE
2004
DELISTED
Sunrise Communications AG American Depositary Shares representing Class A shares
SNRE
| $2.69M | ﹤0.01% |
47,636
+9,594
| +25% | +$543K |
|
2005
Digi International
DGII
$1.27B
| $2.69M | ﹤0.01% |
77,133
+23,584
| +44% | +$822K |
|
2006
Pediatrix Medical
MD
$1.44B
| $2.69M | ﹤0.01% |
187,412
+66,305
| +55% | +$951K |
|
2007
Lazard
LAZ
$5.25B
| $2.68M | ﹤0.01% |
55,929
+18,691
| +50% | +$897K |
|
2008
Honda
HMC
$44.4B
| $2.68M | ﹤0.01% |
92,870
-18,991
| -17% | -$548K |
|
2009
BioNTech
BNTX
$25.1B
| $2.67M | ﹤0.01% |
25,094
-93,840
| -79% | -$10M |
|
2010
Monro
MNRO
$507M
| $2.67M | ﹤0.01% |
179,140
-1,120
| -0.6% | -$16.7K |
|
2011
Hillman Solutions
HLMN
$1.93B
| $2.66M | ﹤0.01% |
373,136
+131,496
| +54% | +$939K |
|
|
ARR
2012
Armour Residential REIT
ARR
$1.72B
| $2.65M | ﹤0.01% |
157,909
+58,822
| +59% | +$989K |
|
2013
NetEase
NTES
$92.3B
| $2.65M | ﹤0.01% |
19,701
+10,283
| +109% | +$1.38M |
|
2014
Integral Ad Science
IAS
$1.41B
| $2.65M | ﹤0.01% |
318,987
+184,601
| +137% | +$1.53M |
|
2015
Planet Labs
PL
$2.98B
| $2.65M | ﹤0.01% |
434,410
+169,827
| +64% | +$1.04M |
|
2016
Collegium Pharmaceutical
COLL
$1.19B
| $2.65M | ﹤0.01% |
89,434
+15,731
| +21% | +$465K |
|
2017
Diebold Nixdorf
DBD
$2.18B
| $2.64M | ﹤0.01% |
47,634
+19,013
| +66% | +$1.05M |
|
2018
UiPath
PATH
$6.25B
| $2.64M | ﹤0.01% |
206,261
-4,999
| -2% | -$64K |
|
2019
Ziff Davis
ZD
$1.5B
| $2.63M | ﹤0.01% |
87,030
+29,985
| +53% | +$908K |
|
2020
MRC Global
MRC
$1.24B
| $2.63M | ﹤0.01% |
191,997
-250,652
| -57% | -$3.44M |
|
2021
Lionsgate Studios Corp.
LION
$1.91B
| $2.63M | ﹤0.01% |
452,095
+409,675
| +966% | +$2.38M |
|
2022
Evolv Technologies
EVLV
$1.37B
| $2.63M | ﹤0.01% |
420,613
+253,861
| +152% | +$1.58M |
|
2023
Dentsply Sirona
XRAY
$2.73B
| $2.63M | ﹤0.01% |
165,409
+32,308
| +24% | +$513K |
|
2024
Marcus & Millichap
MMI
$1.26B
| $2.62M | ﹤0.01% |
85,401
+28,909
| +51% | +$888K |
|
2025
Anavex Life Sciences
AVXL
$762M
| $2.62M | ﹤0.01% |
284,259
+135,584
| +91% | +$1.25M |
|